4Thomas JG, Madigan M.A retrospective study to evaluate a computer based model for amp; ifying, 1 )early anti - fungal intervention and 2) microbial detection of patients at risk for fungemia[ abstract]. Seventh Ammual Focus on Fungal Infections.march, 1997 ,San Amtoioo,TX.
5Uzun O, Ascioglu S, Anaissie El, et al. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia [J ]. Clin Infect Dis,2001,32(12) : 1713 - 1717.
6Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstremn infections in surgical intensive unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey[J]. Clin Infect Dis,2001,33(2) : 177 - 186.
7Pitier D, Monod M, Suter PM, et al. Candida colonization and subsequent infection in critically ill surgical patients[J]. Ann Surg, 1994,220(6) :751 - 758.
8Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A metaanalysis of 16 randomized ,controlled trials[J]. Cancer,2000,89(7):1611 - 1625.
9Kontoyiannis DP, Bodey GP, Mantzoros CS. Fluconazole vs. amphotericin B for the management of candidatmlia in adults: a meta- analysis[J].Mycoses. 2001.44(5) : 125 - 135.
